Albertas Ulys

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

Karim Fizazi, Neal D. Shore, Teuvo L.J. Tammela et al. · New England Journal of Medicine · 2019 · 890 citations · Full text

Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide

Karim Fizazi, Neal D. Shore, Teuvo L.J. Tammela et al. · New England Journal of Medicine · 2020 · 341 citations · Full text

Phase III, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK-700) Plus Prednisone With Placebo Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer That Has Progressed During or After Docetaxel-Based Therapy: ELM-PC 5

Karim Fizazi, Robert J. Jones, Stéphane Oudard et al. · Journal of Clinical Oncology · 2015 · 151 citations · Full text

Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial

Fred Saad, Egils Vjaters, Neal D. Shore et al. · Journal of Clinical Oncology · 2024 · 102 citations · Full text

Clinical significance of miRNA host gene promoter methylation in prostate cancer

Kristina Daniūnaitė, Monika Dubikaityte, Povilas Gibas et al. · Human Molecular Genetics · 2017 · 55 citations · Full text

Engineering, Epigenetic Change, Genetics +19